{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:31:16Z","timestamp":1792668676970,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.ijantimicag.2009.03.019","type":"journal-article","created":{"date-parts":[[2009,5,3]],"date-time":"2009-05-03T04:41:40Z","timestamp":1241325700000},"page":"231-235","source":"Crossref","is-referenced-by-count":78,"title":["Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery"],"prefix":"10.1016","volume":"34","author":[{"given":"April","family":"Barbour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Robert","family":"Rout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kfir","family":"Ben-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Burkhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Derendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2009.03.019_bib1","doi-asserted-by":"crossref","unstructured":"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470\u201385.","DOI":"10.1016\/j.ajic.2004.10.001"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3201\/eid0902.020232","article-title":"Health and economic impact of surgical site infections diagnosed after hospital discharge","volume":"9","author":"Perencevich","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/501572","article-title":"The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs","volume":"20","author":"Kirkland","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0195-6701(88)90089-8","article-title":"A prospective randomized controlled trial of perioperative antibiotic prophylaxis in renal transplantation","volume":"11","author":"Cohen","year":"1988","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF01726445","article-title":"Use of perioperative antibiotic prophylaxis in selected surgical procedures\u2014results of a survey in 889 surgical departments in German hospitals","volume":"19","author":"Kappstein","year":"1991","journal-title":"Infection"},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2009.03.019_bib6","doi-asserted-by":"crossref","first-page":"S880","DOI":"10.1093\/clinids\/6.Supplement_4.S880","article-title":"Antibiotic prophylaxis in surgery","volume":"6","author":"Platt","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/sur.2007.034","article-title":"Effect of body mass index and ertapenem versus cefotetan prophylaxis on surgical site infection in elective colorectal surgery","volume":"9","author":"Itani","year":"2008","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0196-6553(00)90006-3","article-title":"Surgical site infections at the National Cancer Institute in Mexico: a case\u2013control study","volume":"28","author":"Vilar-Compte","year":"2000","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib9","unstructured":"World Health Organization. Obesity and overweight. Geneva: WHO; 2006. Fact sheet No. 311. http:\/\/www.who.int\/mediacentre\/factsheets\/fs311\/en\/index.html [accessed 9 September 2008]."},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0169-409X(00)00113-7","article-title":"Microdialysis in clinical drug delivery studies","volume":"45","author":"Muller","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0091270007312152","article-title":"Clinical microdialysis in skin and soft tissues: an update","volume":"48","author":"Schmidt","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/jac\/dkl284","article-title":"Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis","volume":"58","author":"Burkhardt","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/0091270004273679","article-title":"Tissue penetration of cefpodoxime and cefixime in healthy subjects","volume":"45","author":"Liu","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0091270002424006","article-title":"Comparative target site pharmacokinetics of immediate- and modified-release formulations of cefaclor in humans","volume":"42","author":"de la Pena","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib15","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/00003246-200006000-00009","article-title":"Surgery and intensive care procedures affect the target site distribution of piperacillin","volume":"28","author":"Brunner","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib16","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1128\/AAC.43.8.2056","article-title":"Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients","volume":"43","author":"Muller","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/0267659107080116","article-title":"Tissue and plasma concentrations of cephuroxime during cardiac surgery in cardiopulmonary bypass\u2014a microdialysis study","volume":"22","author":"Mand\u2019ak","year":"2007","journal-title":"Perfusion"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib18","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/AAC.00532-07","article-title":"Pharmacokinetics of single- and multiple-dose oral clarithromycin in soft tissues determined by microdialysis","volume":"51","author":"Traunmuller","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijantimicag.2005.09.017","article-title":"The effect of food on plasma and tissue concentrations of linezolid after multiple doses","volume":"27","author":"Islinger","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1389201023378373","article-title":"Human microdialysis","volume":"3","author":"Stahl","year":"2002","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib21","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/0024-3205(91)90488-W","article-title":"Drug distribution studies with microdialysis. III: extracellular concentration of caffeine in adipose tissue in man","volume":"49","author":"Stahle","year":"1991","journal-title":"Life Sci"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib22","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/AAC.43.10.2345","article-title":"Penetration of moxifloxacin into peripheral compartments in humans","volume":"43","author":"Muller","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib23","unstructured":"GlaxoSmithKline. Prescribing information: Zinacef\u00ae (Cefuroxime for Injection). Research Triangle Park, NC: GlaxoSmithKline; 2007."},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1128\/AAC.9.5.741","article-title":"Cefuroxime: human pharmacokinetics","volume":"9","author":"Foord","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/501620","article-title":"Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee","volume":"20","author":"Mangram","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib26","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1086\/421095","article-title":"Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project","volume":"38","author":"Bratzler","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00003088-199835040-00003","article-title":"Effects of surgery on the pharmacokinetic parameters of drugs","volume":"35","author":"Kennedy","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0749-0704(18)30550-5","article-title":"Effect of anesthesia and surgery on renal function","volume":"3","author":"Sladen","year":"1987","journal-title":"Crit Care Clin"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2009.03.019_bib29","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1086\/321854","article-title":"Does the dose matter?","volume":"33","author":"Craig","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib30","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1128\/AAC.49.10.4372-4374.2005","article-title":"Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes","volume":"49","author":"von Eiff","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib31","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1128\/AAC.37.8.1696","article-title":"Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime","volume":"37","author":"Washington","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0924-8579(96)00310-X","article-title":"Antibiotic resistance in nosocomial isolates in Scotland","volume":"7","author":"Shanahan","year":"1996","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.03.019_bib33","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Cephalosporins\u2014EUCAST clinical MIC breakpoints. 2006-03-31 (v 1.1). http:\/\/www.srga.org\/eucastwt\/MICTAB\/MICcephalosporins.html [accessed 4 March 2009]."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909001526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909001526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T16:14:35Z","timestamp":1558282475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857909001526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0924857909001526"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.03.019","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}